These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36344068)

  • 1. Genetics of Cystic Fibrosis: Clinical Implications.
    Joynt AT; Cutting GR; Sharma N
    Clin Chest Med; 2022 Dec; 43(4):591-602. PubMed ID: 36344068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies.
    Fanen P; Wohlhuter-Haddad A; Hinzpeter A
    Int J Biochem Cell Biol; 2014 Jul; 52():94-102. PubMed ID: 24631642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Genetics of Cystic Fibrosis Transmembrane Conductance Regulator: Genotype and Phenotype.
    Sosnay PR; Raraigh KS; Gibson RL
    Pediatr Clin North Am; 2016 Aug; 63(4):585-98. PubMed ID: 27469177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy in cystic fibrosis.
    Prickett M; Jain M
    Transl Res; 2013 Apr; 161(4):255-64. PubMed ID: 23273902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of cystic fibrosis treatment.
    Carter SC; McKone EF
    Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of Cystic Fibrosis: Clinical Implications.
    Egan ME
    Clin Chest Med; 2016 Mar; 37(1):9-16. PubMed ID: 26857764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding how cystic fibrosis mutations cause a loss of Cl- channel function.
    Sheppard DN; Ostedgaard LS
    Mol Med Today; 1996 Jul; 2(7):290-7. PubMed ID: 8796909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new era of personalized medicine for cystic fibrosis - at last!
    Quon BS; Wilcox PG
    Can Respir J; 2015; 22(5):257-60. PubMed ID: 26083544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis: therapies targeting specific gene defects.
    Thursfield RM; Davies JC
    Paediatr Respir Rev; 2012 Dec; 13(4):215-9. PubMed ID: 23069118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient.
    Egan ME
    Clin Chest Med; 2022 Dec; 43(4):717-725. PubMed ID: 36344076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Therapies to Correct the Cystic Fibrosis Basic Defect.
    Bergeron C; Cantin AM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Molecular Genetics and the long road to treating cystic fibrosis.
    Harris A
    Hum Mol Genet; 2021 Oct; 30(R2):R264-R273. PubMed ID: 34245257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
    Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
    J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
    Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Genomic Medicine in Cystic Fibrosis.
    Chang EH; Zabner J
    Clin Transl Sci; 2015 Oct; 8(5):606-10. PubMed ID: 26073768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in gene therapy for cystic fibrosis lung disease.
    Yan Z; McCray PB; Engelhardt JF
    Hum Mol Genet; 2019 Oct; 28(R1):R88-R94. PubMed ID: 31332440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for cystic fibrosis: new tools for precision medicine.
    Lee JA; Cho A; Huang EN; Xu Y; Quach H; Hu J; Wong AP
    J Transl Med; 2021 Oct; 19(1):452. PubMed ID: 34717671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF.
    Egan ME
    Pediatr Pulmonol; 2021 Feb; 56 Suppl 1(Suppl 1):S32-S39. PubMed ID: 32681713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards the pharmacogenomics of cystic fibrosis.
    Sangiuolo F; D'Apice MR; Bruscia E; Lucidi V; Novelli G
    Pharmacogenomics; 2002 Jan; 3(1):75-87. PubMed ID: 11966405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.